» Articles » PMID: 33818468

Demographic & Clinical Profile of Patients with COVID-19 at a Tertiary Care Hospital in North India

Abstract

Background & Objectives: The COVID-19 pandemic emerged as a major public health emergency affecting the healthcare services all over the world. It is essential to analyze the epidemiological and clinical characteristics of patients with COVID-19 in different parts of our country. This study highlights clinical experience in managing patients with COVID-19 at a tertiary care centre in northern India.

Methods: Clinical characteristics and outcomes of consecutive adults patients admitted to a tertiary care hospital at Chandigarh, India, from April 1 to May 25, 2020 were studied. The diagnosis of SARS-CoV-2 infection was confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) on throat and/or nasopharyngeal swabs. All patients were managed according to the institute's consensus protocol and in accordance with Indian Council of Medical Research guidelines.

Results: During the study period, 114 patients with SARS-CoV-2 infection were admitted. The history of contact with COVID-19-affected individuals was available in 75 (65.8%) patients. The median age of the patients was 33.5 yr (13-79 yr), and there were 66 (58%) males. Of the total enrolled patients, 48 (42%) were symptomatic. The common presenting complaints were fever (37, 77%), cough (26, 54%) and shortness of breath (10, 20.8%). Nineteen (17%) patients had hypoxia (SpO<94%) at presentation and 36 (31%) had tachypnoea (RR >24). Thirty four (29.8%) patients had an accompanying comorbid illness. Age more than 60 yr and presence of diabetes and hypertension were significantly associated with severe COVID-19 disease. Admission to the intensive care unit (ICU) was needed in 18 patients (52%), with three (2.6%) patients requiring assisted ventilation. Mortality of 2.6 per cent (3 patients) was observed.

Interpretation & Conclusions: Majority of the patients with COVID-19 infection presenting to our hospital were young and asymptomatic. Fever was noted only in three-fourth of the patients and respiratory symptoms in half of them. Patients with comorbidities were more vulnerable to complications. Triaged classification of patients and protocol-based treatment resulted in good outcomes and low case fatality.

Citing Articles

Analyzing the Outcomes of COVID-19 Infection on Patients With Comorbidities: Insights From Hospital-Based Study.

Bakthavatchalam R, Bakthavatchalam S, Ravikoti S, Shanmukham B, Reddy K, Pallavali J Cureus. 2024; 16(3):e55358.

PMID: 38562329 PMC: 10982082. DOI: 10.7759/cureus.55358.


Epidemiology of COVID-19 and the Utility of Cycle Threshold (Ct) Values in Predicting the Severity of Disease.

George A, Murugan T, Sampath S, N S M Cureus. 2023; 15(8):e43679.

PMID: 37724229 PMC: 10505265. DOI: 10.7759/cureus.43679.


Symptomatology and Demographic Profile of COVID-19 Patients Admitted to a Tertiary Care Center in India: A Hospital Record-Based Study.

Anupama A, Raman R, Ratheesh R, Palakkunnath S Cureus. 2023; 15(6):e40636.

PMID: 37476129 PMC: 10355227. DOI: 10.7759/cureus.40636.


A comparative study of mortality differences and associated characteristics among elderly and young adult patients hospitalised with COVID-19 in India.

Mittal K, Dhar M, Pathania M, Jha D, Saxena V BMC Geriatr. 2023; 23(1):247.

PMID: 37098474 PMC: 10127169. DOI: 10.1186/s12877-023-03955-6.


Profile and outcome of COVID-19 patients treated at a secondary hospital in Central India during the second wave of the pandemic.

Deepti M, Paul A, Timothy F, Kuttikat S, Karuppusami R, Abhilash K J Family Med Prim Care. 2023; 11(11):7180-7184.

PMID: 36993006 PMC: 10041276. DOI: 10.4103/jfmpc.jfmpc_804_22.


References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

3.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

4.
Marshall J, Cook D, Christou N, Bernard G, Sprung C, Sibbald W . Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995; 23(10):1638-52. DOI: 10.1097/00003246-199510000-00007. View

5.
Sciascia S, Apra F, Baffa A, Baldovino S, Boaro D, Boero R . Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020; 38(3):529-532. View